Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for...
02/06/19
Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan GlobeNewswire
VANCOUVER, British Columbia, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated ...
[more]